Home » Top Tips » Prescriptions and Medications » Medications » Common Questions and Answers about Basiliximab
Andy Stein
June 9, 2026

Common Questions and Answers about Basiliximab

Save article
[favorite_button post_id="" site_id=""]
NHS building external view
This is how the AI article summary could look. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Common Questions and Answers about Basiliximab

Here are 5 common FAQs about basiliximab.


1.❓What is basiliximab used for?

Basiliximab is an immunosuppressant used to prevent acute organ rejection in people receiving a kidney transplant.

It is prescribed as part of an induction regimen immediately after surgery, always used alongside other anti-rejection medications like ciclosporin and corticosteroids.

2.❓How does basiliximab work?

Basiliximab is a monoclonal antibody that targets and blocks the IL-2 receptor (specifically the CD25 subunit) on the surface of activated T-lymphocytes (T-cells).

By blocking this receptor, it prevents T-cells from multiplying and launching an immune attack against the new donor kidney.

3.❓What are the common side effects of basiliximab?

Common side effects include constipation, nausea, diarrhoea, abdominal pain, headache, and insomnia.

Because it is given alongside high-dose steroids and other immunosuppressants, patients also frequently experience high blood pressure, elevated blood cholesterol, and peripheral swelling.

4.❓What serious side effects should people be aware of?

Serious risks include severe hypersensitivity or anaphylactic reactions during the infusion, characterized by hypotension, tachycardia, or respiratory distress.

It can also increase the susceptibility to severe opportunistic infections and potentially elevate the long-term risk of developing lymphomas or other malignancies.

5.❓What strengths does basiliximab come in, and what is a typical dose?

Basiliximab comes as a 20 mg powder reconstituted into a solution for intravenous injection or infusion.

For adults and children weighing 35 kg or more, the standard total dose is 40 mg, given in two separate 20 mg doses: the first within 2 hours before transplant surgery, and the second 4 days after the transplant.


Bonus Question

❓Can lifestyle changes improve basiliximab results?

Yes. Protecting the new kidney requires strict adherence to all post-transplant medical guidelines.

Because basiliximab profoundly suppresses the immune response during the critical early post-operative phase, avoiding crowds, practicing excellent hand hygiene, eating safely prepared foods, and attending all follow-up clinic appointments are vital.

Related Posts

Share this article

Your feedback matters to us!

Comments

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    myHSN is here to help you get the best you can out of the NHS.

    Full of top tips and advice from health care professionals on how the NHS works and how you can make sure it works for you.
    Copyright © 2025 Health Service Navigator